Status epilepticus in pregnancy: a literature review and a protocol proposal

References

• Stephen LJ, Harden C, Tomson T, et al. Management of epilepsy in women. Lancet Neurol. 2019;18:481–491.
   PubMed Web of Science ®Google Scholar
• Battino D, Tomson T, Bonizzoni E, et al. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia. 2013;54:1621–1627.
   PubMed Web of Science ®Google Scholar
• Johannessen Landmark C, Johannessen SI, Tomson T. Host factors affecting antiepileptic drug delivery-Pharmacokinetic variability. Adv Drug Deliv Rev. 2012;64:896–910.
   PubMed Web of Science ®Google Scholar
• Tomson T, Landmark CJ, Battino D. Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications. Epilepsia. 2013;54:405–414.
   PubMed Web of Science ®Google Scholar
• Pariente G, Leibson T, Carls A, et al. Pregnancy-associated changes in pharmacokinetics: a systematic review. Chappell LC, editor. PLOS Med. 2016;13:e1002160.
   PubMed Web of Science ®Google Scholar
• Voinescu PE, Park S, Chen LQ, et al. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy. Neurology. 2018;91:e1228–e1236.
   PubMed Web of Science ®Google Scholar
• Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. 2014;348:g254–g254.
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D, Bromley R, et al. Management of epilepsy in pregnancy: a report from the international league against epilepsy task force on women and pregnancy. Epileptic Disord. 2019;21:497–517.
   PubMed Web of Science ®Google Scholar
• Veroniki AA, Cogo E, Rios P, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017;15:95.
   PubMed Web of Science ®Google Scholar
• Galappatthy P, Liyanage CK, Lucas MN, et al. Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study. BMC Pregnancy Childbirth.2018;18:230.
   PubMed Web of Science ®Google Scholar
• Kusznir Vitturi B, Barreto Cabral F, Mella Cukiert C. Outcomes of pregnant women with refractory epilepsy. Seizure. 2019;69:251–257.
   PubMed Web of Science ®Google Scholar
• Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus - Report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515–1523.
   PubMed Web of Science ®Google Scholar
• Leitinger M, Trinka E, Giovannini G, et al. Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia. 2019;60:53–62.
   PubMed Web of Science ®Google Scholar
• Ascoli M, Ferlazzo E, Gasparini S, et al. Epidemiology and outcomes of status epilepticus. Int J Gen Med. 2021;14:2965–2973.
   PubMed Web of Science ®Google Scholar
• Minicucci F, Ferlisi M, Brigo F, et al. Management of status epilepticus in adults. In: Position paper of the Italian League against Epilepsy. Epilepsy Behav. Academic Press Inc.; 2020. p. 106675.
   Google Scholar
• Valton L, Benaiteau M, Denuelle M, et al. Etiological assessment of status epilepticus. Rev Neurol (Paris). 2020;176:408–426.
   PubMed Web of Science ®Google Scholar
• Carrasco C, Schwalk A, Hwang B, et al. Super-refractory status epilepticus in a 29-year-old pregnant female. SAGE Open Med Case Reports. 2021;9:2050313X2110004.
   Web of Science ®Google Scholar
• Rajiv KR, Radhakrishnan A. Status epilepticus in pregnancy: etiology, management, and clinical outcomes. Epilepsy Behav. 2017;76:114–119.
   PubMed Web of Science ®Google Scholar
• Y-T L, Hsu C-W, Tsai W-C, et al. Status epilepticus associated with pregnancy: a cohort study. Epilepsy Behav. 2016;59:92–97.
   PubMed Web of Science ®Google Scholar
• Li W, Hao N, Xiao Y, et al. Clinical characteristics and pregnancy outcomes of new onset epilepsy during pregnancy. Medicine (Baltimore). 2019;98:e16156.
   PubMedGoogle Scholar
• Talahma M, Sabharwal V, Bukovskaya Y, et al. Ketamine infusion used to successfully control refractory status epilepticus in a pregnant patient. Case Rep Neurol Med;2018:1–4.
   Google Scholar
• Alibas H, Demir N, Agan K, et al. Refractory status epilepticus during pregnancy resolved by cesarian section. Seizure. 2019;65:109–110.
   PubMed Web of Science ®Google Scholar
• Jbili N, Mounir K, Kechna H, et al. A rare case of super-refractory epileptic status in pregnant woman: schizencephaly. Anaesth Crit Care Pain Med. 2019;38:195–198.
   PubMed Web of Science ®Google Scholar
• Shi H, Waldman G, Tobochnik S, et al. Clinical Reasoning: refractory status epilepticus in a primigravida. Neurology. 2019;92:968–972.
   PubMed Web of Science ®Google Scholar
• Park S-H, Kim TJ, S-b K. Super-refractory status epilepticus in a pregnant woman with schizencephaly. Epileptic Disord. 2021;23:523–526.
   PubMed Web of Science ®Google Scholar
• Poggiali E, Morelli N, Terracciano C, et al. Not all is COVID19: a case of eclampsia and posterior reversible encephalopathy syndrome in the emergency room. Acta Biomed. 2021;92:e2021117.
   PubMedGoogle Scholar
• Dam AK, Mishra JCSPK. Treatment of refractory seizures in eclampsia with propofol – a Case Report. Indian J Anaesth. 2004;48:314–315.
   Google Scholar
• Schulze-Bonhage A, Kurthen M, Walger P, et al. Pharmacorefractory status epilepticus due to low vitamin B6 levels during pregnancy. Epilepsia. 2004;45:81–84.
   PubMed Web of Science ®Google Scholar
• Engelhardt K, Trinka E, Franz G, et al. Refractory status epilepticus due to acute hepatic porphyria in a pregnant woman: induced abortion as the sole therapeutic option? Eur J Neurol. 2004;11:693–697.
   PubMed Web of Science ®Google Scholar
• Gunduz A, Beskardes AF, Kutlu A, et al. Herpes encephalitis as a cause of nonconvulsive status epilepticus. Epileptic Disord. 2006;8:57–60.
   PubMed Web of Science ®Google Scholar
• Aladdin Y, Gross DW. Refractory status epilepticus during pregnancy secondary to cavernous angioma. Epilepsia. 2008;49:1627–1629.
   PubMed Web of Science ®Google Scholar
• Legriel S, Merceron S, Pico F, et al. A rare cause of status epilepticus. Intensive Care Med.2011;37:1718–1719.
   PubMed Web of Science ®Google Scholar
• Jeong HS, Oh ES, Lee JH, et al. Refractory status epilepticus spontaneously resolved by parturition. J Epilepsy Res. 2011;1:29–31.
   PubMedGoogle Scholar
• Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16:48–61.
   PubMed Web of Science ®Google Scholar
• Vajda FJE, O’Brien TJ, Graham J, et al. Anti-epileptic drug exposure and risk of foetal death in utero. Acta Neurol Scand. 2018;137:20–23.
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D, Bonizzoni E, et al. Antiepileptic drugs and intrauterine death. Neurology. 2015;85:580–588.
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D, Perucca E. Teratogenicity of antiepileptic drugs. Curr Opin Neurol. 2019;32:246–252.
   PubMed Web of Science ®Google Scholar
• Asranna A, Jose M, Philip RM, et al. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome? Epilepsy Res. 2018;146:121–125.
   PubMed Web of Science ®Google Scholar
• Cohen-Kerem R, Railton C, Oren D, et al. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg. 2005;190:467–473.
   PubMed Web of Science ®Google Scholar
• Mastroianni G, Iannone LF, Roberti R, et al. Management of status epilepticus in patients with liver or kidney disease: a narrative review. Expert Rev Neurother. 2021;21:1251–1264.
   PubMed Web of Science ®Google Scholar
• Lee J, Chen S, Richens A, et al. Serum protein binding of diazepam in maternal and foetal serum during pregnancy. Br J Clin Pharmacol. 1982;14:551–554.
   PubMed Web of Science ®Google Scholar
• Abduljalil K, Pansari A, Jamei M. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy. J Pharmacokinet Pharmacodyn. 2020;47:361–383.
   PubMed Web of Science ®Google Scholar
• Brookfield KF, Su F, Elkomy MH, et al. Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol. 2016;214:737.e1–737.e9.
   PubMed Web of Science ®Google Scholar
• Battino D, Binelli S, Bossi L, et al. Changes in primidone/phenobarbitone ratio during pregnancy and the puerperium. Clin Pharmacokinet. 1984;9:252–260.
   PubMed Web of Science ®Google Scholar
• Yerby MS, Friel PN, McCormick K, et al. Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Res. 1990;5:223–228.
   PubMed Web of Science ®Google Scholar
• Tomson T, Lindbom U, Ekqvist B, et al. Disposition of carbamazepine and phenytoin in pregnancy. Epilepsia. 1994;35:131–135.
   PubMed Web of Science ®Google Scholar
• Tomson T, Palm R, Källén K, et al. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia. 2007;48:1111–1116.
   PubMed Web of Science ®Google Scholar
• Zutshi D, Millis SR, Basha MM, et al. Lacosamide serum concentrations during pregnancy. Epilepsy Behav. 2021;123:108253.
   PubMed Web of Science ®Google Scholar
• Landmark CJ, Rektorli L, Burns ML, et al. Pharmacokinetic data on brivaracetam, lacosamide and perampanel during pregnancy and lactation. Epileptic Disord. 2021;23:426–431.
   PubMed Web of Science ®Google Scholar
• Johannessen Landmark C, Farmen AH, Burns ML, et al. Pharmacokinetic variability of valproate during pregnancy – implications for the use of therapeutic drug monitoring. Epilepsy Res. 2018;141:31–37.
   PubMed Web of Science ®Google Scholar
• Johannessen SI. Pharmacokinetics of valproate in pregnancy: mother-foetus-newborn. Pharm Weekbl Sci Ed. 1992;14:114–117.
   PubMedGoogle Scholar
• Sabers A, Tomson T. Managing antiepileptic drugs during pregnancy and lactation. Curr Opin Neurol. 2009;22:157–161.
   PubMed Web of Science ®Google Scholar
• Kanto JRP. Propofol in cesarean section. A pharmacokinetic and pharmacodynamic study. Methods Find Exp Clin Pharmacol. 1990;12(10):707–711.
   PubMedGoogle Scholar
• Morgan DJ, Blackman GL, Paull JD, et al. Pharmacokinetics and plasma binding of thiopental. II: studies at cesarean section. Anesthesiology. 1981;54:474–480.
   PubMed Web of Science ®Google Scholar
• Trinka E, Brigo F. Benzodiazepines used in the treatment of epilepsy. Treat Epilepsy. 2015;398–417.
   Google Scholar
• Kanto JH. Use of Benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs. 1982;23:354–380.
   PubMed Web of Science ®Google Scholar
• Mandelli M, Morselli PL, Nordio S, et al. Placental transfer of diazepam and its disposition in the newborn. Clin Pharmacol Ther. 1975;17:564–572.
   PubMed Web of Science ®Google Scholar
• Czeizel A, Rockenbauer M, Sørensen H, et al. A population-based case–control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities. Neurotoxicol Teratol. 2004;26:593–598.
   PubMed Web of Science ®Google Scholar
• Sheehy O, Zhao J-P, Bérard A. Association between incident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion. JAMA Psychiatry. 2019;76:948.
   PubMed Web of Science ®Google Scholar
• Wikner BN, Stiller C-O, Bergman U, et al. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf. 2007;16:1203–1210.
   PubMed Web of Science ®Google Scholar
• Ban L, Tata LJ, West J, et al. Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. Vermund SH, editor. PLoS One. 2012;7:e43462.
   PubMed Web of Science ®Google Scholar
• Ornoy A, Arnon J, Shechtman S, et al. Is benzodiazepine use during pregnancy really teratogenic? Reprod Toxicol. 1998;12:511–515.
   PubMed Web of Science ®Google Scholar
• Safra MJ, Oakley GP. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet. 1975;2:478–480.
   PubMed Web of Science ®Google Scholar
• Saxén I, Saxén L. Association between maternal intake of diazepam and oral clefts. Lancet. 1975;306:498.
   Google Scholar
• Rosenberg L, Mitchell AA, Parsells JL, et al. Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med. 1983;309:1282–1285.
   PubMed Web of Science ®Google Scholar
• Ban L, West J, Gibson JE, et al. First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a united kingdom population-based cohort study. Homberg J, editor. PLoS One. 2014;9:e100996.
   PubMed Web of Science ®Google Scholar
• Tasci Y, Demir B, Dilbaz S, et al. Use of diazepam for hyperemesis gravidarum. J Matern Neonatal Med. 2009;22:353–356.
   PubMed Web of Science ®Google Scholar
• Gidai J, Ács N, Bánhidy F, et al. No association found between use of very large doses of diazepam by 112 pregnant women for a suicide attempt and congenital abnormalities in their offspring. Toxicol Ind Health. 2008;24:29–39.
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Erös E, Rockenbauer M, et al. Short-term oral diazepam treatment during pregnancy. Clin Drug Investig. 2003;23:451–462.
   PubMed Web of Science ®Google Scholar
• Kjaer D, Horvath-Puhó E, Christensen J, et al. Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study. Pharmacoepidemiol Drug Saf. 2007;16:181–188.
   PubMed Web of Science ®Google Scholar
• Bonnot O, Vollset SE, Godet PF, et al. Maternal exposure to lorazepam and anal atresia in newborns: results from a hypothesis-generating study of benzodiazepines and malformations. J Clin Psychopharmacol. 2001;21:456–458. :
   PubMed Web of Science ®Google Scholar
• Tinker SC, Reefhuis J, Bitsko RH, et al. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National birth defects prevention study, 1997–2011. Birth Defects Res. 2019;111:613–620.
   PubMed Web of Science ®Google Scholar
• McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol. 1994;8:461–475.
   PubMed Web of Science ®Google Scholar
• Olutoye OA, Baker BW, Belfort MA, et al. Food and Drug Administration warning on anesthesia and brain development: implications for obstetric and fetal surgery. Am J Obstet Gynecol. 2018;218:98–102.
   PubMed Web of Science ®Google Scholar
• Kitaoka S, Hatogai J, Iimura R, et al. Relationship between low midazolam metabolism by cytochrome P450 3A in mice and the high incidence of birth defects. J Toxicol Sci. 2018;43:65–74.
   PubMed Web of Science ®Google Scholar
• Galletly DC, Williams TB, Robinson BJ. Periodic cardiovascular and ventilatory activity during midazolam sedation. Br J Anaesth. 1996;76:503–507.
   PubMed Web of Science ®Google Scholar
• Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med. 1997;15:357–365.
   PubMedGoogle Scholar
• Wilson CM, Dundee JW, Moore J, et al. A comparison of the early pharmacokinetics of midazolam in pregnant and nonpregnant women. Anaesthesia. 1987;42:1057–1062.
   PubMed Web of Science ®Google Scholar
• Lin AE, Peller AJ, Westgate M-N, et al. Clonazepam use in pregnancy and the risk of malformations. Birth Defects Res Part A Clin Mol Teratol. 2004;70:534–536.
   PubMedGoogle Scholar
• Almgren M, Källén B, Lavebratt C. Population-based study of antiepileptic drug exposure in utero—Influence on head circumference in newborns. Seizure. 2009;18:672–675.
   PubMed Web of Science ®Google Scholar
• Duley L, Gülmezoglu AM, Henderson-Smart DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.Cochrane Database Syst Rev. 2010.
   Web of Science ®Google Scholar
• Euser AG, Cipolla MJ. Magnesium Sulfate for the Treatment of Eclampsia: a brief review. Stroke. 2009;40:1169–1175.
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Walker GJ, et al. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2010.
   Web of Science ®Google Scholar
• Shepherd E, Salam RA, Manhas D, et al. Antenatal magnesium sulphate and adverse neonatal outcomes: a systematic review and meta-analysis. Myers JE, editor. PLOS Med. 2019;16:e1002988.
   PubMed Web of Science ®Google Scholar
• Hiilesmaa VK, Teramo K, Granström M-L, et al. Fetal head growth retardation associated with maternal antiepileptic drugs. Lancet. 1981;318:165–167.
   Google Scholar
• Battino D, Kaneko S, Andermann E, et al. Intrauterine growth in the offspring of epileptic women: a prospective multicenter study. Epilepsy Res. . 1999;36:53–60.
   PubMed Web of Science ®Google Scholar
• Weston J, Bromley R, Jackson CF, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev. 2016.
   Web of Science ®Google Scholar
• Hernández-Díaz S, McElrath TF, Pennell PB, et al. Fetal growth and premature delivery in pregnant women on antiepileptic drugs. Ann Neurol. 2017;82:457–465.
   PubMed Web of Science ®Google Scholar
• The north american antiepileptic drug pregnancy registry. updated data through [Internet]. 2020. Cited 2020 Oct 31 https://www.aedpregnancyregistry.org/wp-content/uploads/2021/08/The-NA-AED-Pregnancy-Registry-AES-2020.pdf.
   Google Scholar
• Tomson T, Battino D, Bonizzoni E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17:530–538.
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D, Perucca E. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol. 2016;15:210–218.
   PubMed Web of Science ®Google Scholar
• Reinisch JM, Sanders SA, Mortensen EL, et al. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA. 1995;274:1518–1525.
   PubMed Web of Science ®Google Scholar
• Hanson JW, Myrianthopoulos NC, Harvey MAS, et al. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr. 1976;89:662–668.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Finnell RH, et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology. 2006;67(3):407–412.
   PubMed Web of Science ®Google Scholar
• Wide K, Henning E, Tomson T, et al. Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr. 2007;91:409–414.
   Google Scholar
• Bromley R, Weston J, Adab N, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev. 014; 2020.
   Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013;12:244–252.
   PubMed Web of Science ®Google Scholar
• Highlights of prescribing information. Dilantin® [Internet]. 2017. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/010151s046lbl.pdf.
   Google Scholar
• Manford M. Recent advances in epilepsy. J Neurol. 2017;264:1811–1824.
   PubMed Web of Science ®Google Scholar
• Lattanzi S, Cagnetti C, Foschi N, et al. Lacosamide during pregnancy and breastfeeding. Neurol Neurochir Pol. 2017;51:266–269.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Pennell PB, May RC, et al. Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy. Neurology. 2020;94:e1502–e1511.
   PubMed Web of Science ®Google Scholar
• Coste J, Blotiere P-O, Miranda S, et al. Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France. Sci Rep. 2020;10:17362.
   PubMed Web of Science ®Google Scholar
• Watkins LV, Cock HR, Angus-Leppan H, et al. Valproate and the Pregnancy Prevention Programme: exceptional circumstances. Br J Gen Pract. 2019;69:166–167.
   PubMed Web of Science ®Google Scholar
• Jentink J, Loane MA, Dolk H, et al. Valproic Acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362:2185–2193.
   PubMed Web of Science ®Google Scholar
• Roullet FI, Lai JKY, Foster JA. In utero exposure to valproic acid and autism — a current review of clinical and animal studies. Neurotoxicol Teratol. 2013;36:47–56.
   PubMed Web of Science ®Google Scholar
• Macfarlane A, Greenhalgh T. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach? BMC Pregnancy Childbirth. 2018;18:200.
   PubMed Web of Science ®Google Scholar
• Christensen J, Grønborg TK, Sørensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309:1696.
   PubMed Web of Science ®Google Scholar
• Beezhold JN, Fagard D, Harabajiu C. Valproate used during pregnancy: what should be done? Eur Psychiatry. 2017;41:S419–S419.
   Web of Science ®Google Scholar
• Soares de Moura R, Silva GAM, Tano T, et al. Effect of propofol on human fetal placental circulation. Int J Obstet Anesth. 2010;19:71–76.
   PubMed Web of Science ®Google Scholar
• Neuman G, Koren G. Safety of Procedural Sedation in Pregnancy. J Obstet Gynaecol Canada. 2013;35:168–173.
   PubMedGoogle Scholar
• Jauniaux E, Gulbis B, Shannon C, et al. Placental propofol transfer and fetal sedation during maternal general anaesthesia in early pregnancy. Lancet. 1998;352:290–291.
   PubMed Web of Science ®Google Scholar
• Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation 8th edition: a reference guide to fetal and neonatal risk. Obstet Med. 2009;2:89.
   Google Scholar
• Product information. Diprivan (propofol) [Internet]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019627s066lbl.pdf.
   Google Scholar
• Tumukunde J, Lomangisi DD, Davidson O, et al. Effects of propofol versus thiopental on Apgar scores in newborns and peri-operative outcomes of women undergoing emergency cesarean section: a randomized clinical trial. BMC Anesthesiol. 2015;15:63.
   PubMed Web of Science ®Google Scholar
• Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(10):2802–2818.
   PubMedGoogle Scholar
• Little B, Chang T, Chucot L, et al. Study of ketamine as an obstetric anesthetic agent. Am J Obstet Gynecol. 1972;113:247–260.
   PubMed Web of Science ®Google Scholar
• Houthoff Khemlani K, Weibel S, Kranke P, et al. Hypnotic agents for induction of general anesthesia in cesarean section patients a systematic review and meta-analysis of randomized controlled trials. J Clin Anesth. 2018;48:73–80.
   PubMed Web of Science ®Google Scholar
• Schultetus RR, Paulus DA, Spohr GL. Haemodynamic effects of ketamine and thiopentone during anaesthetic induction for Caesarean section. Can Anaesth Soc J. 1985;32:592–596.
   PubMedGoogle Scholar
• Shi Y, Li J, Chen C, et al. Ketamine modulates Zic5 expression via the notch signaling pathway in neural crest induction. Front Mol Neurosci 2018;11. .
   Google Scholar
• Malaiyandi D, James E, Peglar L, et al. Neurocritical Care of the pregnant patient. Curr Treat Options Neurol. 2021;23:22.
   PubMed Web of Science ®Google Scholar
• Rajiv KR, Radhakrishnan A. Status epilepticus in pregnancy – can we frame a uniform treatment protocol? Epilepsy Behav. 2019;101:106376.
   PubMed Web of Science ®Google Scholar
• Trinka E, Höfler J, Leitinger M, et al. Pharmacotherapy for status epilepticus. Drugs. 2015;75(13):1499–1521.
   PubMed Web of Science ®Google Scholar
• Prasad M, Krishnan PR, Sequeira R, et al. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev. 2014. DOI:https://doi.org/10.1002/14651858.CD003723.pub3
   Google Scholar
• Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345:631–637.
   PubMed Web of Science ®Google Scholar
• Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591–600.
   PubMed Web of Science ®Google Scholar
• Trinka E, Höfler J, Leitinger M, et al. Pharmacologic treatment of status epilepticus. Expert Opin Pharmacother. 2016;17(4):513–534.
   PubMed Web of Science ®Google Scholar
• Royal college of obstetricians and gynaecologists. In: Epilepsy in pregnancy: green top guideline. Vol. 68. Nice; 2016. 8–27
   Google Scholar
• NICE. Epilepsies : diagnosis and management [Internet]. 2021. [cited 2021 Dec 9]. Available from https://www.nice.org.uk/guidance/cg137.
   Google Scholar
• Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103–2113.
   PubMed Web of Science ®Google Scholar
• Trinka E, Höfler J, Zerbs A, et al. Efficacy and safety of intravenous valproate for status epilepticus: a systematic review. CNS Drugs. 2014;28(7):623–639.
   PubMed Web of Science ®Google Scholar
• Brigo F, Storti M, Del Felice A, et al. IV Valproate in generalized convulsive status epilepticus: a systematic review. Eur J Neurol. 2012;19(9):1180–1191.
   PubMed Web of Science ®Google Scholar
• Holtkamp M. Pharmacotherapy for refractory and super-refractory status epilepticus in adults. Drugs. 2018;78(3):307–326.
   PubMed Web of Science ®Google Scholar
• Marawar R, Basha M, Mahulikar A, et al. Updates in refractory status epilepticus. Crit Care Res Pract. 2018:1–19. https://www.hindawi.com/journals/ccrp/2018/9768949/
   Google Scholar
• Gimovsky AC, Fritton K, Viscusi E, et al. Evaluating the Use of ketamine for pain control with sickle cell crisis in pregnancy. A&A Pract. 2018;10:20–22.
   PubMed Web of Science ®Google Scholar
• Fishel Bartal M, Sibai BM. Eclampsia in the 21st century. Am J Obstet Gynecol. 2020 .
   Google Scholar
• Liu S, Joseph KS, Liston RM, et al. Incidence, Risk Factors, and Associated Complications of Eclampsia. Obstet Gynecol. 2011;118:987–994.
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2010 .
   Web of Science ®Google Scholar
• The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345:1455–1463.
   PubMed Web of Science ®Google Scholar
• Rai S, Drislane FW. Treatment of Refractory and Super-refractory Status Epilepticus. Neurotherapeutics. 2018;15(3):697–712.
   PubMed Web of Science ®Google Scholar
• Vossler DG, Bainbridge JL, Boggs JG, et al. Treatment of Refractory Convulsive Status Epilepticus: a Comprehensive Review by the American Epilepsy Society Treatments Committee. Epilepsy Curr. 2020;20:245–264.
   PubMed Web of Science ®Google Scholar
• Rajiv K, Menon R, Sukumaran S, et al. Status epilepticus related to pregnancy: devising a protocol for use in the intensive care unit. Neurol India. 2018;66:1629.
   PubMed Web of Science ®Google Scholar
• Kaplan PW, Norwitz ER, Ben-Menachem E, et al. Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav. 2007;11:283–291.
   PubMed Web of Science ®Google Scholar
• Kasai M, Aoki S, Kobayashi N, et al. Status epilepticus due to brain tumor during pregnancy. Clin Case Rep. 2016;4:333–335.
   PubMedGoogle Scholar